Lupus patients in an emergency unit. Causes of consultation,hospitalization and outcome. A cohort study

Abstract

The objectives were to determine causes of consultation, hospitalization and outcome in a cohort of lupus patients in an emergency unit.

Patients with systemic lupus erythematosus (SLE) who visited the emergency department for consultation from 1 September 1996 to 17 May 1997 were included in the study. They were evaluated during the visit by looking at 100 variables such as demographic, socioeconomic, clinical, therapeutical, behavioral, (compliance), emotional (Beck depression inventory), disease activity, (Mex-SLEDAI), disease severity (Lupus SDI), chronic damage (SLICC-ACR), and physician' and patient' global assessments of severity. All causes of consultation, hospitalization and outcome were registered. Descriptive statistics, univariate analysis and multiple logistic regression were used for analysis. Significance was set at the 0.05 level.

180 patients were included. 164 were female, mean age 31.7=11.39 y, mean Mex SLEDAI score 3.8, mean SLICC-ACR 1.3. Fever, poliarthralgia and abdominal pain were the main causes of consultation with 26, 25 and 18 cases each. 49 patients were hospitalized and these were statistically different than non-hospitalized patients in level of formal education (10.2 vs 11.8, P ‘ 0.03); compliance (7.6 vs 9, P ‘ 0.0001); malar rash (57% vs 82%, OR, 95% CI ‘ 0.28, 0.13–0.62, P ‘ 0.0008), chloroquine daily dose intake (45 vs 77 mg, P ‘ 0.04); disease severity in physician' global assessments (5.6 vs 2.1, P ‘ 0.0001) and Beck depression inventory (21 vs 16, P ‘ 0.01). Multiple logistic regression identified physician' global assessment, fewer ACR criteria and higher SLICC-ACR scores as the main variables associated with hospitalization. Five patients died; two with community acquired pneumonia, one with pancreatitis, multiple thromboses, and sepsis, one with pulmonary hemorrhage; and one with pulmonary thromboembolism.

In conclusion, poor compliance, low level of formal education, severity, depression, lower ACR criteria and higher SLICC-ACR scores were important variables identified with hospitalization. Chloroquine use seemed to have a protective effect. Causes of death were related to infections and antiphospholipid syndrome.

Keywords

systemic lupus erythematosus emergency medicine compliance depression

Get full access to this article

View all access options for this article.

References

Pistiner M , Wallace DJ , Nessim S et al. Lupus erythematosus in the 1980s: a survey of 570 patients . Semin Arthritis Rheum 1991; 21: 55–64 .

Van Der Straeten C , Nathan W , Rothschild J et al. Rapidly fatal pneumococcal septicemia in systemic lupus erythematosus . J Rheumatol 1987; 14: 1177–1180 .

Hellmann DB , Petri M , Whiting-O'Keefe Q . Fatal infection in systemic lupus erythematosus: the role of opportunistic organisms . Medicine 1987; 66: 341–348 .

Sánchez-Guerrero J , Alarcón-Segovia D . Salmonella pericarditis with tamponade in systemic lupus erythematosus . Br J Rheumatol 1990; 29: 69–71 .

Drenkard C , Villa AR , Alarco ón-Segovia D , Pérez-Vázquez ME . Influence of the antiphospholipid syndrome in the survival of patients with systemic lupus erythematosus . J Rheumatol 1994; 21: 1067–1072 .

Petri M , Genovese M . Incidence of and risk factors for hospitalization in systemic lupus erythematosus, a prospective of the Hopkins lupus cohort . J Rheumatol 1992: 19: 1559–1565 .

Tan EM , Cohen AS , Fries JF et al. Special article: the 1982 revised criteria for the classification of systemic lupus erythematosus . Arthritis Rheum 1982; 25: 1271–1277 .

Suarez-Mendoza AA , Cardiel MH , Caballero-Uribe CV et al. Measurement of depression in Mexican patients with rheumatoid arthritis: validity of the Beck Depression Inventory . Arthritis Care Res 1997; 10: 194–199 .

Abello-Banfi M , Cardiel MH , Ruiz-Mercado R , Alarco ón-Segovia D . Quality of life in rheumatoid arthritis: validation of a Spanish version of the Arthritis Impact Measurement Scales (Spanish-AIMS) . J Rheumatol 1994; 21: 1250–1255 .

10.

Guzman J , Cardiel MH , Arce Salinas A et al. Measurement of disease activity in systemic lupus erythematosus prospective validation of 3 clinical indices . J Rheumatol 1992; 19: 1551–1558 .

11.

Katz JD , Senecal JL , Rivest Ch et al. A simple severity of disease index for systemic lupus erythematosus . Lupus 1993; 2: 119–123 .

12.

Gladman DD , Ginzler E , Goldsmith CH et al. Development and initial validation of the systemic lupus erythematosus international collaborating Clinics/American College of Rheumatology damage index for systemic lupus erythematosus . Arthritis Rheum 1996; 39: 363–369 .

13.

Hughes GRV . The antiphospholipid syndrome . Ten years on. Lancet 1993; 342: 341–344 .

14.

Abu-Shakra M , Urowitz MB , Gladman DF , Gough J . Mortality studies in systemic lupus erythematosus. Results from a single center. I. Causes of death . J Rheumatol 1995; 22: 1259–1264 .

15.

Kraus A , Cabral AR , Cifuentes J , Alarco ón-Segovia D . Listeriosis in patients with connective tissue diseases . J Rheumatol 1994; 21: 635–638 .

16.

Karlson EW , Daltroy LH , Lew RA et al. The relationship of socioeconomic status, race, and modifiable risk factors to outcomes in patients with systemic lupus erythematosus . Arthritis Rheum 1997; 40: 47–56 .

17.

Ward MM , Lotstein DS , Bush TM et al. Psychosocial correlates of morbidity in women with systemic lupus erythematosus . J Rheumatol 1999; 26: 2153–2158 .

18.

Glave-Testino C , Cardiel MH , Arce-Salinas A , Alarco ón-Segovia D . Factors associated with disease severity in Mexican patients with rheumatoid arthritis . Clin Exp Rheumatol 1994; 12: 589–594 .

19.

Ward MM , Lotstein DS , Bush TM et al. Psychosocial correlates of morbidity in women with systemic lupus erythematosus . J Rheumatol 1999; 26: 2153–2158 .

20.

Karlson EW , Daltroy LH , Lew RA et al. The independence and stability of socioeconomic predictors of morbidity in systemic lupus erythematosus . Arthritis Rheum 1995; 38: 267–273 .

21.

22.

Sutcliffe N , Clarke AE , Levinton C et al. Associates of health status in patients with systemic lupus erythematosus . J Rheumatol 1999; 26: 2352–2356 .

23.

Herna óndez-Cruz B , Tapia N , Villa AR , Cardiel MH . Mortalidad en pacientes con lupus eritematoso generalizado. Estudio de casos y controles. (Resumen) . Rev Mex Reum 1997; 12 (Suppl 1): 27–27 .

24.

The Canadian Hydroxychloroquine Study Group . A randomized trial of the effect of withdrawing hydroxychloroquine sulphate in systemic lupus erythematosus . New Engl J Med 1991; 324: 150–154 .

25.

The Canadian Hydroxychloroquine Study Group . A long term study of hydroxychloroquine withdrawal on exacerbations in systemic lupus erythematosus . Lupus 1998; 7: 80–85 .